Company Valuation: Immunovia AB

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2024 2025 2026 2027 2028
Market Cap 1 1,697 595.2 92.66 152.7 130.5 - -
Change - -64.93% - 64.79% -14.54% - -
Enterprise Value (EV) 1 1,443 526.7 92.66 76.09 63.5 56.5 112.5
Change - -63.5% - -17.88% -16.55% -11.02% 99.12%
P/E -0.11x -0.04x -0.01x -0.54x -1.94x -4.85x -9.7x
PBR 0.04x 0.02x - - - - -
PEG - -0.01x - 0x 0x 0.1x 0.2x
Capitalization / Revenue 1,775x 494x - 203x 40.8x 7.54x 2.37x
EV / Revenue 1,510x 437x - 101x 19.8x 3.27x 2.05x
EV / EBITDA -9.78x -3.17x - -0.97x -0.71x -0.71x -2.39x
EV / EBIT -8.66x -2.76x - -0.95x -0.7x -0.69x -2.25x
EV / FCF -9.27x -2.97x - -0.91x -0.68x -0.65x -2.01x
FCF Yield -10.8% -33.6% - -110% -148% -154% -49.8%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -689 -743 -93 -0.42 -0.1 -0.04 -0.02
Distribution rate - - - - - - -
Net sales 1 0.956 1.204 - 0.752 3.2 17.3 55
EBITDA 1 -147.6 -166.2 - -78.06 -89 -80 -47
EBIT 1 -166.6 -191.2 - -80.38 -91 -82 -50
Net income 1 -156 -168.1 -76.54 -145.9 -91 -82 -50
Net Debt 1 -254.1 -68.47 - -76.6 -67 -74 -18
Reference price 2 75.0000 26.3000 0.5460 0.2270 0.1940 0.1940 0.1940
Nbr of stocks (in thousands) 22,632 22,632 169,711 672,667 672,667 - -
Announcement Date 2/17/22 2/23/23 2/25/25 2/24/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
59.15x4.76x15.91x0.36% 16.36B
41.7x - - 1.94% 1.78B
-11.41x1.33x5.85x-.--% 1.24B
18.97x2.73x9.2x1.23% 1.14B
57.12x - - 0.78% 582M
45.63x - - - 447M
18.58x2.62x11.19x1.83% 382M
24.71x4.26x14.61x1.88% 362M
Average 31.81x 3.14x 11.35x 1.15% 2.79B
Weighted average by Cap. 50.19x 4.37x 14.76x 0.58%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA